DHG: DHG Pharmaceutical Joint Stock Company - Summary | Jitta

DHG Pharmaceutical Joint Stock Company

VNM:DHG

Price
₫100,000.00
Loss Chance
49.2%
4.60JITTA SCORE
133.75%Over Jitta Line
Jitta Ranking
267 / 622
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (59)
Recent Business Performance (44)
Financial Strength (65)
Return to Shareholders (58)
Competitive Advantage (53)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningEarning decline from 2022-2025
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.60
133.75%
4.34
205.69%
3.94
171.55%
Pharmaceuticals
5.90
74.70%
3.71
> 1,000%
4.51
71.29%
COMPANY DESCRIPTION
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceutical Joint Stock Company was founded in 1974 and is headquartered in Can Tho, Vietnam. DHG Pharmaceutical Joint Stock Company is a subsidiary of Taisho Pharmaceutical Co., Ltd.